CHYM insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Adam Frankel General Counsel	102,002	$33.31	20%	403K	Sep 15, 2026	Sep 16, 2026

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Cynthia Marshall Director	20,000	$33.09	41%	29K	Sep 11, 2026	Sep 14, 2026

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ryan King Co-Founder, Director	42,421	$35.15	n/a	n/a	Sep 9, 2026	Sep 10, 2026

What stands out

Three insiders sold more than 25% of vested holdings: Adam Frankel (46% of holdings, $3.8M, 97% under a disclosed plan), Amine Asmerom (55% of holdings, $2.9M, all under a disclosed plan) and Cynthia Marshall (75% of holdings, $1.4M, none under a disclosed plan).Adam Frankel: largest sale, Sep 15, 2026 · Amine Asmerom: largest sale, Nov 26, 2025 · Cynthia Marshall: largest sale, Mar 2, 2026

Outside holders and shareholders represented on the board, not part of management, sold heavily: DST Global Advisors Ltd ($1.07B) and James Feuille ($31.3M).DST Global Advisors Ltd: largest sale, Aug 19, 2026 · James Feuille: largest sale, Sep 11, 2026

Selling picked up in the last 90 days: officers and directors sold 1.49M shares, against an average of 65K per 90 days earlier in the period. Most of it was Christopher Britt (850K shares in the last 90 days, 4.9% of holdings) and Ryan King (417K shares in the last 90 days); 99% of these sales were under disclosed plans.Christopher Britt: largest recent sale, Sep 1, 2026 · Ryan King: largest recent sale, Aug 6, 2026

Percentages cover 10 of 11 officers and directors. Left out: Ryan King (holdings couldn't be fully reconciled). Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is the insider's vested stake at the start of the period (Oct 8, 2025). The gold part is what they sold.

SoldRest of starting stakeAdded during the period

Christopher Britt

Chief Executive Officer, Director

5.2% · $27.7MDisclosed plan

Ryan King

Co-Founder, Director

No bar: holdings couldn't be fully reconciled.

$12.8MDisclosed plan

Adam Frankel

General Counsel

Sold 46%, but 79K shares were added (mostly vesting), so the stake grew

46% · $3.8M97% planned

Amine Asmerom

Chief Accounting Officer

55% · $2.9MDisclosed plan

Matthew Newcomb

Chief Financial Officer

Sold 2.8%, but 143K shares were added (mostly vesting), so the stake grew

2.8% · $2.2MDisclosed plan

All 6 sellers

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesNo plan disclosed

Outside holders, reported separately

DST Global Advisors Ltd sold $1.07B, James Feuille (for the outside shareholder represented on the board) sold $31.3M and Shawn Carolan (for the outside shareholder represented on the board) sold $19.2M in the past 12 months. Large shareholders and the funds or companies that board members represent are not part of management, so they are left out of the figures above.

Details

Common questions

Is the Chime Financial, Inc. CEO selling stock?

Yes. Christopher Britt sold 900K shares ($27.7M, 5.2% of starting holdings) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are Chime Financial, Inc. insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 97% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 3% had no disclosed plan. A trading plan schedules sales in advance.

Are any Chime Financial, Inc. insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

How much of their stake did Chime Financial, Inc. insiders sell?

About 5.5% overall. As a group they ended with more shares than they started with. These figures leave out Ryan King, the largest holder (holdings couldn't be fully reconciled). That covers the 12 months to Oct 8, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold6 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Christopher Britt Chief Executive Officer, Director	$27.7M 900K shares	5.2%	Disclosed plan
Ryan King Co-Founder, Director	$12.8M 417K shares	i No percentage: holdings couldn't be fully reconciled.	Disclosed plan
Adam Frankel General Counsel	$3.8M 121K shares	46%	97% under a disclosed plan
Amine Asmerom Chief Accounting Officer	$2.9M 124K shares	55%	Disclosed plan
Matthew Newcomb Chief Financial Officer	$2.2M 75K shares	2.8%	Disclosed plan
Cynthia Marshall Director	$1.4M 55K shares	75%	No plan disclosed

Board members representing outside shareholders, reported separately: James Feuille (the shareholder sold $31.3M), Shawn Carolan (the shareholder sold $19.2M). Details

Outside holder, reported separately: DST Global Advisors Ltd (a 10% owner, not part of management). Sold $1.07B (32.50M shares) from Aug 6, 2026 to Sep 14, 2026. Latest filing

The full ownership picture10 of 11 insiders fully reconciled · 11 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 8, 2025

Sold

Held Oct 8, 2026

Still held

Christopher Britt

Chief Executive Officer, Director

17.28M

−900K

16.46M

95%

Vesting, gifts, unvested awards and holding lines for Christopher Britt

+125Kshares vested or exercised

0gifted (net of own trusts)

−44Kwithheld by the company for taxes

1.00M → 875Kunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Class A Common Stock	357,458	360,417
Britt Living Trust	Class A Common Stock	0	0
Spouse	Class A Common Stock	0	0
Direct	Class B Common Stock	15,110	15,110
Britt Living Trust	Class B Common Stock	14,643,564	14,155,103
Tiger Trust	Class B Common Stock	500,000	500,000
Aloha Trust	Class B Common Stock	500,000	500,000
Tiger GRAT	Class B Common Stock	466,599	466,599
Aloha GRAT	Class B Common Stock	466,599	466,599
Spouse	Class B Common Stock	333,000	0

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,628,665	$7.67	Jan 27, 2030	$65.8M
900,000	$13.89	Mar 28, 2033	$16.9M
700,000	$17.35	Mar 29, 2034	$10.7M
200,000	$17.35	Mar 29, 2034	$3.1M
200,000	$17.35	Mar 29, 2034	$3.1M
900,563	$21.62	Mar 11, 2036	$10.0M

Estimate: options held × ($32.70 − strike price), using the most recent insider trade price on Form 4 (Sep 16, 2026), not a market close.

Ryan King

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -303,930 shares on May 11, 2026 (Peninsula Living Trust). See the filing Sales and other transactions for Ryan King are complete.

Co-Founder, Director

n/a

−417K

n/a

Vesting, gifts, unvested awards and holding lines for Ryan King

+75Kshares vested or exercised

0gifted (net of own trusts)

−17Kwithheld by the company for taxes

600K → 525Kunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -303,930 shares on May 11, 2026 (Peninsula Living Trust). The balances below are as reported, not verified totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Class A Common Stock	178,317	191,667
King Family Trust	Class A Common Stock	0	0
Peninsula Living Trust	Class A Common Stock	0	0
King Gift Trust EK	Class A Common Stock	0	0
King Gift Trust LK	Class A Common Stock	0	0
King Gift Trust SK	Class A Common Stock	0	0
Direct	Class B Common Stock	21,899	14,408
King Family Trust	Class B Common Stock	12,183,739	11,810,900
King Irrevocable Trust A	Class B Common Stock	900,000	900,000
King Irrevocable Trust M	Class B Common Stock	900,000	900,000
Peninsula Living Trust	Class B Common Stock	303,930	0
King Grantor Trust MV	Class B Common Stock	225,000	225,000
King Gift Trust AK	Class B Common Stock	87,700	87,700
King Gift Trust AV	Class B Common Stock	87,700	87,700
King Gift Trust CV	Class B Common Stock	87,700	87,700
King Gift Trust EK	Class B Common Stock	87,700	0
King Gift Trust LK	Class B Common Stock	87,700	0
King Gift Trust MK	Class B Common Stock	87,700	87,700
King Gift Trust NV	Class B Common Stock	87,700	87,700
King Gift Trust SK	Class B Common Stock	87,700	0
Maureen Vergara	Class B Common Stock	43,850	43,850
King Family Trust	Common Stock	0	22,475

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,367,925	$7.67	Jan 27, 2030	$59.3M
885,602	$13.89	Mar 28, 2033	$16.7M
700,000	$17.35	Mar 29, 2034	$10.7M
200,000	$17.35	Mar 29, 2034	$3.1M
700,000	$17.35	Mar 29, 2034	$10.7M
200,000	$17.35	Mar 29, 2034	$3.1M
450,282	$21.62	Mar 11, 2036	$5.0M

Estimate: options held × ($32.70 − strike price), using the most recent insider trade price on Form 4 (Sep 16, 2026), not a market close.

Matthew Newcomb

Includes unvested RSUs, amount not disclosed.

Chief Financial Officer

2.68M

−75K

2.69M

+0.4%

Vesting, gifts, unvested awards and holding lines for Matthew Newcomb

0shares vested or exercised

0gifted (net of own trusts)

−56Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct includes unvested RSUs, amount not disclosed	Class A Common Stock	536,927	478,172
2019 Newcomb Fox Family Trust	Class A Common Stock	2,147,872	2,216,070

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
103,417	$0.68	Nov 5, 2028	$3.3M
325,000	$6.19	Jul 22, 2030	$8.6M
375,000	$13.89	Feb 6, 2033	$7.1M
266,667	$15.70	Dec 24, 2033	$4.5M
233,400	$27.90	Mar 5, 2035	$1.1M
383,400	$27.90	Mar 5, 2035	$1.8M
281,426	$21.62	Mar 11, 2036	$3.1M

Estimate: options held × ($32.70 − strike price), using the most recent insider trade price on Form 4 (Sep 16, 2026), not a market close.

Mark Troughton

Includes unvested RSUs, amount not disclosed.

President and Interim CFO

2.64M

4.17M

no sales

Vesting, gifts, unvested awards and holding lines for Mark Troughton

0shares vested or exercised

0gifted (net of own trusts)

−89Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct includes unvested RSUs, amount not disclosed	Class A Common Stock	2,636,693	4,173,999

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
500,000	$6.19	Jul 22, 2030	$13.3M
233,333	$13.89	Feb 6, 2033	$4.4M
600,000	$15.70	Nov 28, 2033	$10.2M
233,400	$27.90	Mar 5, 2035	$1.1M
383,400	$27.90	Mar 5, 2035	$1.8M
160,000	$23.92	Dec 7, 2035	$1.4M
412,758	$21.62	Mar 11, 2036	$4.6M

Estimate: options held × ($32.70 − strike price), using the most recent insider trade price on Form 4 (Sep 16, 2026), not a market close.

Adam Frankel

Minor difference of -38,534 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Includes unvested RSUs, amount not disclosed.

General Counsel

261K

−121K

365K

+40%

Vesting, gifts, unvested awards and holding lines for Adam Frankel

+79Kshares vested or exercised

0gifted (net of own trusts)

−44Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct includes unvested RSUs, amount not disclosed	Class A Common Stock	261,279	364,828

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
360,500	$16.56	Aug 31, 2033	$5.8M
100,000	$23.51	Dec 3, 2034	$919K
166,600	$27.90	Mar 5, 2035	$800K
213,567	$16.56	Aug 31, 2033	$3.4M
225,142	$21.62	Mar 11, 2036	$2.5M

Estimate: options held × ($32.70 − strike price), using the most recent insider trade price on Form 4 (Sep 16, 2026), not a market close.

Reconciliation: minor difference of -38,534 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Amine Asmerom

Minor difference of 1,195 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Includes unvested RSUs, amount not disclosed.

Chief Accounting Officer

224K

−124K

281K

+25%

Vesting, gifts, unvested awards and holding lines for Amine Asmerom

0shares vested or exercised

0gifted (net of own trusts)

−43Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct includes unvested RSUs, amount not disclosed	Class A Common Stock	224,336	280,975

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,000	$13.89	Mar 25, 2033	$188K
75,048	$21.62	Mar 11, 2036	$832K

Estimate: options held × ($32.70 − strike price), using the most recent insider trade price on Form 4 (Sep 16, 2026), not a market close.

Reconciliation: minor difference of 1,195 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Cynthia Marshall

Includes unvested RSUs, amount not disclosed.

Director

74K

−55K

29K

40%

Vesting, gifts, unvested awards and holding lines for Cynthia Marshall

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct includes unvested RSUs, amount not disclosed	Class A Common Stock	72,795	28,548
Spouse	Class A Common Stock	375	375
Child	Class A Common Stock	375	375

Susan Decker

Includes unvested RSUs, amount not disclosed.

Director

71K

82K

no sales

Vesting, gifts, unvested awards and holding lines for Susan Decker

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct includes unvested RSUs, amount not disclosed	Class A Common Stock	14,295	25,048
SJCE Family LP	Class A Common Stock	57,000	57,000

James Dunne III

Includes unvested RSUs, amount not disclosed.

Director

71K

85K

no sales

Vesting, gifts, unvested awards and holding lines for James Dunne III

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct includes unvested RSUs, amount not disclosed	Class A Common Stock	71,295	84,950

Shawn Carolan

Minor difference of 287,178 shares. Footnote reports an exempt acquisition without its size; amount derived from the balance change. Includes unvested RSUs, amount not disclosed. Exempt acquisition noted in a footnote; amount derived from the balance change. Shares held through MM Inflection, L.P, MMEF XIV, L.P, MMSOP, L.P and others belong to an outside shareholder this director represents; they are listed under "Board members representing outside shareholders", not here.

Director

7.6K

306K

no sales

Vesting, gifts, unvested awards and holding lines for Shawn Carolan

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Exempt acquisition noted in a footnote; amount derived from the balance change.
Shares held through MM Inflection, L.P, MMEF XIV, L.P, MMSOP, L.P and others belong to an outside shareholder this director represents; they are listed under "Board members representing outside shareholders", not here.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct includes unvested RSUs, amount not disclosed	Class A Common Stock	7,628	304,843
Trust	Class A Common Stock	0	716

Reconciliation: minor difference of 287,178 shares. Footnote reports an exempt acquisition without its size; amount derived from the balance change.

James Feuille

Minor difference of 193,992 shares. Footnote reports an exempt acquisition without its size; amount derived from the balance change. Includes unvested RSUs, amount not disclosed. Exempt acquisition noted in a footnote; amount derived from the balance change. Shares held through CO VI, CV VII, Crosslink Bayview VII, LLC and others belong to an outside shareholder this director represents; they are listed under "Board members representing outside shareholders", not here.

Director

7.6K

217K

no sales

Vesting, gifts, unvested awards and holding lines for James Feuille

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Exempt acquisition noted in a footnote; amount derived from the balance change.
Shares held through CO VI, CV VII, Crosslink Bayview VII, LLC and others belong to an outside shareholder this director represents; they are listed under "Board members representing outside shareholders", not here.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct includes unvested RSUs, amount not disclosed	Class A Common Stock	7,628	23,315
an irrevocable trust	Class A Common Stock	0	148,746
a revocable trust	Class A Common Stock	0	45,246

Reconciliation: minor difference of 193,992 shares. Footnote reports an exempt acquisition without its size; amount derived from the balance change.

10 of 11 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (6 exactly, 4 with a minor or footnoted difference). For 1 we show sales but not holdings; the ! icon on that row explains why. Percentages cover 10 of 11 officers and directors. Left out: Ryan King (holdings couldn't be fully reconciled). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$50.9M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $50.9M across 1,692,659 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $49.4M · 97%

The lighter segment is sales with no plan disclosed in the filing ($1.5M), including tax-related sales outside a plan.

No plan disclosed · $1.5M

Sales with no 10b5-1 plan and no tax reference in the filing. $1.4M of it is Cynthia Marshall. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Cynthia Marshall, Mar 2, 2026

Taxes

293,479 shares ($6.4M) were withheld by the company for taxes, which isn't a market sale.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Christopher Britt Chief Executive Officer, Director	900K	$27.7M	100%	54%	Jan 9, 2026 to Sep 1, 2026
Ryan King Co-Founder, Director	417K	$12.8M	100%	25%	Aug 6, 2026 to Sep 9, 2026
Adam Frankel General Counsel	121K	$3.8M	97%	8%	Dec 8, 2025 to Sep 15, 2026
Amine Asmerom Chief Accounting Officer	124K	$2.9M	100%	6%	Nov 26, 2025 to Sep 8, 2026
Matthew Newcomb Chief Financial Officer	75K	$2.2M	100%	4%	Jan 9, 2026 to Aug 6, 2026
Cynthia Marshall Director	55K	$1.4M	0%	3%	Mar 2, 2026 to Sep 11, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$1.7M	$1.7M	$0	$0
Dec 2025	$200K	$200K	$0	$0
Jan 2026	$1.8M	$1.8M	$0	$0
Feb 2026	$0	$0	$0	$0
Mar 2026	$780K	$0	$0	$780K
Apr 2026	$0	$0	$0	$0
May 2026	$0	$0	$0	$0
Jun 2026	$107K	$0	$0	$107K
Jul 2026	$0	$0	$0	$0
Aug 2026	$33.7M	$33.7M	$0	$0
Sep 2026	$12.6M	$11.9M	$0	$662K
Oct 2026	$0	$0	$0	$0

Board members representing outside shareholders (2)Listed and sourced; not part of the management totals or the answer line

Directors whose reported holdings sit mostly in an investment fund or a corporate shareholder they represent, not in their own name, with beneficial ownership disclaimed except for their own financial interest. Listed and sourced here; not part of the management totals or the answer line. Shares a fund hands to its own investors are distributions, not sales.

Board member

Held Oct 8, 2025

Sold

Held Oct 8, 2026

Still held

James Feuille

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -16,545,146 shares on Dec 11, 2025 (Crosslink Crossover Fund VI, L.P). See the filing Sales and other transactions for James Feuille are complete.

Director

n/a

−983K

n/a

Vesting, gifts, unvested awards and holding lines for James Feuille

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

In-kind distributions to the fund's own investors are labeled as distributions, not sales.
An owner entity could not be identified from the footnotes.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -16,545,146 shares on Dec 11, 2025 (Crosslink Crossover Fund VI, L.P). The balances below are as reported, not verified totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Crosslink Crossover Fund VI, L.P	Class A Common Stock	23,766,250	6,560,707
Crosslink Ventures VII, L.P	Class A Common Stock	0	8,275,067
Crosslink Ventures VII-B, L.P	Class A Common Stock	0	3,545,896
Crosslink Bayview VII, LLC	Class A Common Stock	0	876,661
Crosslink Ventures VII Holdings, LLC	Class A Common Stock	0	0
Crosslink Crossover Fund VI, L.P	Common Stock	23,766,254	23,766,254
Unresolved (see footnote)	Series A Preferred Stock	16,166,706	16,166,706
Unresolved (see footnote)	Series A-2 Preferred Stock	5,069,680	5,069,680
Unresolved (see footnote)	Series B Preferred Stock	2,385,950	2,385,950

Shawn Carolan

Minor difference of -8,431,700 shares. The difference is shares the fund distributed in kind to its own investors, not sales. In-kind distributions to the fund's own investors are labeled as distributions, not sales.

Director

50.99M

−579K

41.98M

82%

Vesting, gifts, unvested awards and holding lines for Shawn Carolan

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

In-kind distributions to the fund's own investors are labeled as distributions, not sales.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Menlo Inflection I, L.P	Class A Common Stock	17,442,713	4,825,155
Menlo Ventures XIV, L.P	Class A Common Stock	0	3,432,840
MMEF XIV, L.P	Class A Common Stock	0	51,155
Menlo Entrepreneurs Fund XIV, L.P	Class A Common Stock	0	44,100
MMSOP, L.P	Class A Common Stock	0	78,450
Menlo Inflection II, L.P	Class A Common Stock	0	0
MM Inflection, L.P	Class A Common Stock	0	0
Menlo Entrepreneurs Inflection Fund, L.P	Class A Common Stock	0	0
Menlo Inflection I, L.P	Common Stock	17,442,713	17,442,713
Menlo Inflection I, L.P	Series C Preferred Stock	15,523,620	15,523,620
Menlo Inflection II, L.P	Series E Preferred Stock	579,313	579,313

Reconciliation: minor difference of -8,431,700 shares. The difference is shares the fund distributed in kind to its own investors, not sales.

James Feuille: 3.03M shares were distributed in kind to the fund's own investors. These are distributions, not sales.

Shawn Carolan: 8.43M shares were distributed in kind to the fund's own investors. These are distributions, not sales.

Is this normal? Selling year by yearNot enough history to compare

Not enough history to compare: fewer than three earlier years of filings.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 8, 2026 Latest 12 months	1.69M	6	$50.9M
Oct 8, 2025 1 year earlier · filings don't cover the whole year	n/a	n/a	n/a
Oct 8, 2024 2 years earlier · filings don't cover the whole year	n/a	n/a	n/a
Oct 9, 2023 3 years earlier · filings don't cover the whole year	n/a	n/a	n/a
Oct 9, 2022 4 years earlier · filings don't cover the whole year	n/a	n/a	n/a
Oct 9, 2021 5 years earlier · filings don't cover the whole year	n/a	n/a	n/a

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty1 insider whose holdings couldn't be fully reconciled

Ryan King: holdings couldn't be fully reconciled (difference of -552,046 shares). Balance changed without a matching transaction, and the footnote does not state the amount: -303,930 shares on May 11, 2026 (Peninsula Living Trust). Filing, May 11, 2026

Footnote: "As a result of this conversion, the Reporting Person no longer serves as attorney-in-fact for the holder and no longer has beneficial ownership over such shares. | The shares are held by Peninsula Living Trust, for which the Reporting Person served as attorney-in-fact."

Adam Frankel: minor difference of -38,534 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Amine Asmerom: minor difference of 1,195 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Shawn Carolan: minor difference of 287,178 shares. Footnote reports an exempt acquisition without its size; amount derived from the balance change.

James Feuille: minor difference of 193,992 shares. Footnote reports an exempt acquisition without its size; amount derived from the balance change.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology130 filings from SEC EDGAR, and how we read them

All 130 Forms 3, 4 and 5 filed for Chime Financial, Inc. (SEC CIK 1795586) from Jun 11, 2025 to Sep 16, 2026, retrieved from SEC EDGAR on Oct 8, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Chime Financial, Inc. insiders sold $50.9M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Outside holders, reported separately

Common questions

Is the Chime Financial, Inc. CEO selling stock?

Why are Chime Financial, Inc. insiders selling?

Are any Chime Financial, Inc. insiders buying?

How much of their stake did Chime Financial, Inc. insiders sell?

The evidence

No plan disclosed · $1.5M

Taxes

Sales by month